At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 976 enrolled
Drug / intervention
Eevadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IV, Prospective, Randomized, Exploratory, Multicenter, Eeva™ Trial (Time Lapse Eeva - TiLE)
In Brief
A Phase 4 clinical trial evaluating Eeva for Fertility. Completed, enrolled 976 participants across 23 sites in 9 countries.
Detailed Summary
The purpose of the study was to explore the added value of adjunctive use of Early Embryo Viability Assessment (Eeva) with morphological grading in identifying optimal embryos for transfer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFertility
CountriesCanada, Denmark, France, Germany, Italy, Norway, Spain, Sweden, United Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2015
Enrollment StartJun 2015
Primary CompletionFeb 2017
TodayJul 2026
First PostedApr 15, 2015
Enrollment StartJun 29, 2015
Primary CompletionFeb 9, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.2 years ago
Interventions
Eevadevice
Embryos of subjects randomized in this group were assessed using Eeva System and morphological grading to identify optimal embryos for transfer.